Integrative Health Technologies, Inc. (IHTI) Stock

About Integrative Health Technologies, Inc.

Integrative Health Technologies, Inc. offers a variety of professional services to the healthcare and nutritional sectors, including paid clinical trials, research and development initiatives, and specialized consulting and analytical testing. The company boasts an extensive historical database, comprising over 30,000 diagnostic tests collected over two decades, which is utilized for tracking disease patterns. Additionally, it deploys both mobile and fixed dual-energy X-ray absorptiometry (DEXA) units designed to accurately assess total and regional bone density, as well as body fat and lean mass. The firm also furnishes comprehensive blood chemistry reports, detailing 43 distinct biochemical markers such as HDL, LDL, C-reactive protein, thyroid function, electrolyte balance, red and white blood cell counts, and glucose levels. Established in 1999, Integrative Health Technologies, Inc. is headquartered in San Antonio, Texas.

Integrative Health Technologies, Inc. (IHTI) stock trades at $0.00 with a market capitalization of $1626. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Integrative Health Technologies, Inc. generates a return on equity (ROE) of 0.00%, return on capital employed of 0.49%, an operating margin of 8.65%, a net profit margin of 8.65%.

Official website: ihtresearch.com